Point72 Hong Kong LTD Amneal Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $17,822 - $31,939	8,823 New	8,823 $18,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $15,769 - $23,365	-5,239 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $9,976 - $12,508	2,558 Added 95.41%	5,239 $22,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $1,331 - $1,971	-337 Reduced 11.17%	2,681 $13,000
Q3 2021 Nov 15, 2021	BUY	$4.31 - $5.64 $2,848 - $3,728	661 Added 28.04%	3,018 $16,000
Q2 2021 Aug 16, 2021	SELL	$5.12 - $6.82 $5,150 - $6,860	-1,006 Reduced 29.91%	2,357 $12,000
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $15,940 - $24,818	3,363 New	3,363 $23,000
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $27,495 - $37,728	-6,961 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $24,641 - $36,684	6,961 New	6,961 $27,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $60,198 - $114,523	-20,975 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $51,598 - $112,216	20,975 New	20,975 $73,000
Q3 2019 Nov 14, 2019	SELL	$2.29 - $7.1 $16,224 - $50,303	-7,085 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $12,957 - $28,751	-2,012 Reduced 22.12%	7,085 $51,000
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $22,446 - $28,062	-1,891 Reduced 17.21%	9,097 $129,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $140,979 - $231,447	10,770 Added 4940.37%	10,988 $149,000
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $51,659 - $76,450	-3,150 Reduced 93.53%	218 $5,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $46,983 - $68,033	3,368 New	3,368 $55,000

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.